⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRDF News
Cardiff Oncology, Inc. Common Stock
Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference
globenewswire.com
CRDF
Form 8-K
sec.gov
CRDF
Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
globenewswire.com
CRDF
Form 8-K
sec.gov
CRDF
Form 8-K
sec.gov
CRDF
Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update
globenewswire.com
CRDF
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CRDF
Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity
globenewswire.com
CRDF
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
globenewswire.com
CRDF
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
globenewswire.com
CRDF